Promote HIV chemoprophylaxis research, don't prevent it

被引：58

作者：

Grant, RM ^{[1
]}

Buchbinder, S

Cates, W

Clarke, E

Coates, T

Cohen, MS

Delaney, M

Flores, G

Goicochea, P

Gonsalves, G

Harrington, M

Lama, JR

MacQueen, KM

Moore, JP

Peterson, L

Sanchez, J

Thompson, M

Wainberg, MA

机构：

[1] Gladstone Inst Virol & Immunol, San Francisco, CA USA

[2] Univ Calif San Francisco, San Francisco, CA 94143 USA

[3] San Francisco Dept Publ Hlth, San Francisco, CA USA

[4] Family Hlth Int, Res Triangle Pk, NC 27709 USA

[5] Ghana Hlth Serv, Accra, Ghana

[6] Univ Calif Los Angeles, Los Angeles, CA 90024 USA

[7] Univ N Carolina, Chapel Hill, NC USA

[8] Project Inform, San Francisco, CA USA

[9] Asociac Civil Impacta Salud & Educ, Lima, Peru

[10] Gay Mens Hlth Crisis Inc, New York, NY USA

[11] Treatment Act Grp, New York, NY USA

[12] Cornell Univ, Weill Med Coll, New York, NY USA

[13] AIDS Res Consortium Atlanta, Atlanta, GA USA

[14] McGill Univ, AIDS Ctr, Montreal, PQ, Canada

来源：

SCIENCE | 2005年 / 309卷 / 5744期

关键词：

D O I：

10.1126/science.1116204

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

[No abstract available]

引用

页码：2170 / 2171

页数：2

共 19 条

[1]

[Anonymous], REP GLOB AIDS EP

[2]

[Anonymous], NO TIME LOSE GETTING

[3] Phase I/II trial of the pharmacokinetics, safety, and antiretroviral activity of tenofovir disoproxil fumarate in human immunodeficiency virus-infected adults [J].

Barditch-Crovo, P ;

Deeks, SG ;

Collier, A ;

Safrin, S ;

Coakley, DF ;

Miller, M ;

Kearney, BP ;

Coleman, RL ;

Lamy, PD ;

Kahn, JO ;

McGowan, I ;

Lietman, PS .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (10) :2733-2739

[4] HIV sexual risk behavior over 36 months of follow-up in the world's first HIV vaccine efficacy trial [J].

Bartholow, BN ;

Buchbinder, S ;

Celum, C ;

Goli, V ;

Koblin, B ;

Para, M ;

Marmor, M ;

Novak, RM ;

Mayer, K ;

Creticos, C ;

Orozco-Cronin, P ;

Popovic, V ;

Mastro, TD .

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2005, 39 (01) :90-101

[5] Assessment of mitochondrial toxicity in human cells treated with tenofovir: Comparison with other nucleoside reverse transcriptase inhibitors [J].

Birkus, G ;

Hitchcock, MJM ;

Cihlar, T .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (03) :716-723

[6] Efficacy and safety of tenofovir DF vs stavuldine in combination therapy in antiretroviral-naive patients - A 3-year randomized trial [J].

Gallant, JE ;

Staszewski, S ;

Pozniak, AL ;

DeJesus, E ;

Suleiman, JMAH ;

Miller, MD ;

Coakley, DF ;

Lu, B ;

Toole, JJ ;

Cheng, AK .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (02) :191-201

[7]

HALIMA Y, 2005, INT AIDS SOC STAK HO

[8]

HAWKINS T, 2004, 15 INT AIDS C BANGK

[9]

Horton R, 2004, NEW YORK REV BOOKS, V51, P7

[10] Effects of a behavioural intervention to reduce acquisition of HIV infection among men who have sex with men: the EXPLORE randomised controlled study [J].

Koblin, B ;

Chesney, M ;

Coates, T ;

Mayer, K ;

Agredano, F ;

Aguilu, E ;

Barahona, R ;

Bell, K ;

Borges, C ;

Burnias, M ;

Cayabayab, M ;

Church, D ;

Cohn, A ;

Colon, Y ;

Dargon, J ;

DeSousa, N ;

Erdman, J ;

Gagne, J ;

Goodhue, E ;

Jimenez, J ;

Johnson, W ;

Knauz, R ;

Labiosa, W ;

Lara, A ;

LeBlanc, D ;

Longo, V ;

Manseau, M ;

Miller, M ;

Mimiaga, M ;

Mohns, E ;

Montenegro, A ;

Pantalone, D ;

Patino, O ;

Rogers, T ;

Ruiz, E ;

Safren, S ;

Salomon, L ;

Silva, J ;

van der Leeden, L ;

VanDerwarker, R ;

Weber, C ;

McKirnan, D ;

Batticks, A ;

Bird, J ;

Bradshaw, L ;

Brown, R ;

Buckingham, T ;

Carson, K ;

Chubinsky, I .

LANCET, 2004, 364 (9428) :41-50

← 1 2 →